P
Paul C. Lambert
Researcher at Karolinska Institutet
Publications - 219
Citations - 16155
Paul C. Lambert is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Population & Relative survival. The author has an hindex of 54, co-authored 202 publications receiving 13874 citations. Previous affiliations of Paul C. Lambert include University of Leicester & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data
TL;DR: Many routinely used summary methods provide widely ranging estimates when applied to sparse data with high imbalance between the size of the studies' arms, including Mantel-Haenszel summary estimates using the alternative continuity correction factors, which gave the least biased results for all group size imbalances.
Journal ArticleDOI
Meta-analysis of individual participant data: rationale, conduct, and reporting
TL;DR: The rationale for an individual participant data meta-analysis is described, how to conduct this type of study is outlined and how to interpret the data is outlined.
Journal ArticleDOI
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
Clare L Gillies,Keith R. Abrams,Paul C. Lambert,Nicola J. Cooper,Alex J. Sutton,Ronald T. Hsu,Kamlesh Khunti +6 more
TL;DR: Lifestyle and pharmacological interventions reduce the rate of progression to type 2 diabetes in people with impaired glucose tolerance and seem to be at least as effective as drug treatment.
Journal ArticleDOI
Further development of flexible parametric models for survival analysis
Paul C. Lambert,Patrick Royston +1 more
TL;DR: A new command is introduced, stpm2, that extends the methodology of Royston and Parmar's flexible parametric survival models and enables simple quantification of differences between any two covariate patterns through calculation of time-dependent hazard ratios, hazard differences, and survival differences.
Journal ArticleDOI
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
Melina Arnold,Mark J. Rutherford,Mark J. Rutherford,Aude Bardot,Jacques Ferlay,Therese M.-L. Andersson,Tor Åge Myklebust,Hanna E. Tervonen,Vicky Thursfield,David Ransom,Lorraine Shack,Ryan Woods,Donna Turner,Suzanne Leonfellner,S Ryan,Nathalie Saint-Jacques,Prithwish De,Carol McClure,Agnihotram V. Ramanakumar,H Stuart-Panko,Gerda Engholm,Paul M. Walsh,Christopher Jackson,Sally Vernon,Eileen Morgan,Anna Gavin,David S. Morrison,Dyfed Wyn Huws,Geoff Porter,John Butler,Heather Bryant,David C. Currow,Sara Hiom,D. Max Parkin,Peter Sasieni,Paul C. Lambert,Paul C. Lambert,Bjørn Møller,Isabelle Soerjomataram,Freddie Bray +39 more
TL;DR: Progress in cancer control over the study period was evident for stomach, colon, lung (in males), and ovarian cancer, and the impact of comorbidity are likely the main determinants of patient outcomes.